| Symbol | FEED |
|---|---|
| Name | NANOVIBRONIX, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Industrial Specialties |
| Address | 525 EXECUTIVE BOULEVARD, ELMSFORD, New York, 10523, United States |
| Telephone | +1 914 233-3004 |
| Fax | — |
| — | |
| Website | https://www.nanovibronix.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001326706 |
| Description | NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low frequency, low intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients as well as through distributor agreements. Additional info from NASDAQ: |
ENvue Medical Launches AI Training Platform Establishing Artificial Intelligence Foundation for Robotic Feeding Tube Navigation
Read moreENvue Medical Expands into Burn Intensive Care Unit at Major Academic Health Network
Read moreENvue Medical Announces Publication of Landmark Independent Study Highlighting Significant Safety, Time-, and Cost-Saving Benefits of ENvue Navigation Platform in Multi-Hospital System
Read moreNew Form EFFECT - ENvue Medical, Inc. <b>Filed:</b> 2026-05-28 <b>AccNo:</b> 9999999995-26-001794 <b>Size:</b> 2 KB
Read moreNew Form 424B3 - ENvue Medical, Inc. <b>Filed:</b> 2026-05-28 <b>AccNo:</b> 0001493152-26-025615 <b>Size:</b> 159 KB
Read moreNew Form S-3 - ENvue Medical, Inc. <b>Filed:</b> 2026-05-18 <b>AccNo:</b> 0001493152-26-024231 <b>Size:</b> 437 KB
Read more📋 Glibert Christian Michael (substantial shareholder) plans to sell 30K shares of ENvue Medical, Inc (at $1.17 each, total $35K) Filed: May 13, 2026 | ID: 000006
Read moreENvue Medical Secures Three-Year Contract Renewal at 12-Hospital U.S. Health Network as the ENvue™ Navigation Platform Becomes Standard of Care
Read moreENvue Medical Adds to Intellectual Property Portfolio by Securing USPTO Notice of Allowance for Ultrasound-Enhanced Cannabinoid Drug Delivery Technology
Read more